These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38185136)

  • 1. Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?
    Hoenigl M; Prattes J
    Lancet Respir Med; 2024 Mar; 12(3):183-185. PubMed ID: 38185136
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.
    Le Daré B; Boglione-Kerrien C; Reizine F; Gangneux JP; Bacle A
    Crit Care; 2021 Apr; 25(1):152. PubMed ID: 33879175
    [No Abstract]   [Full Text] [Related]  

  • 4. [What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis].
    Scharf C; Zoller M; Liebchen U
    Anaesthesist; 2021 May; 70(5):432-433. PubMed ID: 33635372
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
    Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
    Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis.
    Reizine F; Tadié JM; Grégoire M; Tarte K; Gangneux JP
    Lancet Microbe; 2024 Aug; 5(8):100861. PubMed ID: 38670134
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    Koehler P; Bassetti M; Chakrabarti A; Chen SCA; Colombo AL; Hoenigl M; Klimko N; Lass-Flörl C; Oladele RO; Vinh DC; Zhu LP; Böll B; Brüggemann R; Gangneux JP; Perfect JR; Patterson TF; Persigehl T; Meis JF; Ostrosky-Zeichner L; White PL; Verweij PE; Cornely OA; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Lancet Infect Dis; 2021 Jun; 21(6):e149-e162. PubMed ID: 33333012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.
    Prattes J; Giacobbe DR; Bassetti M; Gangneux JP; Hoenigl M;
    Intensive Care Med; 2024 Aug; 50(8):1375-1377. PubMed ID: 38980361
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
    Mian P; Trof RJ; Beishuizen A; Masselink JB; Cornet AD; Sportel ET
    J Clin Pharm Ther; 2022 Mar; 47(3):383-385. PubMed ID: 34431552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Pulmonary Aspergillosis: Can We Breathe Easy?
    Miller RA
    Transplantation; 2020 Dec; 104(12):2473-2474. PubMed ID: 32080159
    [No Abstract]   [Full Text] [Related]  

  • 14. Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis.
    Serris A; Ouedrani A; Uhel F; Gazzano M; Bedarida V; Rouzaud C; Bougnoux ME; Raphalen JH; Poirée S; Lambotte O; Martin-Blondel G; Lanternier F
    Front Immunol; 2022; 13():900522. PubMed ID: 35720319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pulmonary aspergillosis: help is on the way.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Feb; 4(2):83. PubMed ID: 26868621
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.
    Imoto W; Himura H; Matsuo K; Kawata S; Kiritoshi A; Deguchi R; Miyashita M; Kaga S; Noda T; Yamamoto K; Yamada K; Uchida K; Nishimura T; Yamamoto H; Mizobata Y; Kakeya H
    J Infect Chemother; 2021 Jun; 27(6):911-914. PubMed ID: 33674201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation after surgical resection of pulmonary aspergillosis in 5 patients with acute leukemia.
    Motohashi K; Ito S; Hagihara M; Sakai R; Tanaka M; Kawano T; Maruta A; Ishigatsubo Y; Kanamori H
    Rinsho Ketsueki; 2009 May; 50(5):430-4. PubMed ID: 19483405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.
    Massart N; Reizine F; Dupin C; Legay F; Legris E; Cady A; Rieul G; Barbarot N; Magahlaes E; Fillatre P
    Infect Dis (Lond); 2023 Apr; 55(4):263-271. PubMed ID: 36694427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19-associated pulmonary aspergillosis: adding insult to injury.
    Bruno G; Fabrizio C; Buccoliero GB
    Lancet Microbe; 2020 Jul; 1(3):e106. PubMed ID: 32835340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.